Fintel reports that on October 15, 2025, HC Wainwright & Co. reiterated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 325.00% Upside As of ...
We recently published 10 Stocks Losing Big Amid Market Boom. Microbot Medical Inc. (NASDAQ:MBOT) is one of the worst performers on Thursday. Microbot extended its losing streak to a fourth consecutive ...
Microbot Medical announced that the U.S. FDA has granted 510(k) clearance for its LIBERTY® System, the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular ...
MBOT’s main value driver is its LIBERTY robot. This is a disposable, portable endovascular robot that has great potential. LIBERTY showed strong ACCESS-PVI data and now awaits FDA 510(k) clearance for ...
Get Boston news and weather from NewsCenter 5. Live weekdays at 4:30 a.m. to 7 a.m., 12 p.m., 4 p.m. to 6:30 p.m., 10 p.m. and 11 p.m.Saturdays at 5 a.m. to 7 a.m., 8 ...
Microbot Medical Inc. (NASDAQ:MBOT), a medical device company with a market capitalization of $190 million, reported Monday it issued a total of 2,967,953 shares of its common stock from August 11 ...
Investing.com - Microbot Medical (NASDAQ:MBOT) maintained its Buy rating and $9.00 price target at H.C. Wainwright following a new patent grant for its LIBERTY endovascular robotic system. The stock ...
Discover the top 5 tutorials that every aspiring artist should watch to master drawing clothes. From fabric folds to outfit design, these guides will help you level up your skills and make your ...
Microbot Medical Inc. (MBOT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...